Alternative Investment Fund Management

A Luxembourg based Alternative Investment Fund Manager dedicated to Healthcare Private Equity investments. Building on an investment history that stretches back to more than 30 years.

Our long-term, fundamental value approach utilizes our extensive research and risk management capabilities and seeks to provide superior returns.

RCSL: B275545 CSSF Reg no. A00003659
Disclaimer for Publication
The European Commission’s Sustainable Action Plan has three objectives:
(1) To reorient capital flows towards sustainable investment in order to achieve sustainable and inclusive growth;
(2) To manage financial risks stemming from climate change, environmental degradation, and social issues; and
(3) To foster transparency and long-termism in financial and economic activity.

 It is a response to recommendations from the high-level expert group on sustainable finance, which were submitted to the Commission in January 2018. Already, the European Parliament has adopted an amendment to Regulation 2016/1011 to introduce a framework for EU climate transition and EU Paris-aligned benchmarks, an amendment to the Delegated Regulation 2017/565 to integrate environmental, social, and governance (ESG) considerations into investment advice and portfolio management, and an amendment to Delegated Regulation (EU) 2017/2359 to integrate ESG considerations and preferences into the investment advice for insurance-based investment products. It has also prepared a series of related reports, including an EU Taxonomy Regulation, benchmarks, EU green bond standard, and climate-related disclosures.
SFDR which is part of a broader legislative package under the European Commission’s Sustainable Action Plan, came into effect on 10 March 2021. To meet the SFDR disclosure requirements, BPI CAPITAL Sàrl identifies, assesses and, where possible and appropriate, seeks to manage sustainability risks for the Partnership as part of its risk management process. BPI CAPITAL Sàrl believes that the integration of this risk analysis could help to enhance the long-term value of the portfolio for Investors, in accordance with the investment objective and Investment Policy of the Partnership. However, due to the nature of the investment objective, sustainability risks are not integrated in the investment decisions. For the avoidance of doubt, the Partnership is not promoting environmental or social characteristics within the meaning of article 8 of SFDR nor has sustainable investment as its objective within the meaning of article 9 of SFDR. For the purposes of Article 6 of the EU Taxonomy Regulation, BPI CAPITAL Sàrl confirms that the investments underlying this financial product (i.e. the Partnership) do not take into account the EU criteria for environmentally sustainable economic activities. As regards disclosures obligations under article 4(1) of SFDR, BPI CAPITAL Sàrl confirms that the AIF does not take into account the negative impacts due to investments - Article 4 (1) (b).
Our Vision
Our vision is to become a leading player in the pharmaceutical industry, known for our strong investment performance, ethical practices, and contribution to accessible and affordable healthcare worldwide
BPI Life Sciences Fund

A private equity fund in Luxembourg that will acquire pharmaceutical and life sciences opportunities across Europe to offer Partners the benefits of collective management of their funds.

The fund will employ a niche private equity strategy – integrating products and assets into a sustainable platform whose shares will be divested over time. The fund will commit resources to drive value creation, support global distribution, and generate strong returns.

The fund will be committed to upholding ESG standards and advancing social impact in alignment with the Sustainable Development Goals. The fund will advance access to healthcare for underserved populations, create jobs, and improve livelihoods.

RCSL: B280503 CSSF Reg no. V9517

Bernard Tannoury

Managing Partner & Chief Executive Officer

Ahmad Shukr

Managing Partner & Chief Investment Officer

Jesse Schulman, PhD

Investment Executive

Jad Haddad

Investment Analyst

Charbel Slaiby

Risk Management Analyst

  • 2C, Parc d'Activité, L-8308 Capellen, G.D. Luxembourg